Mercy Helps Position St. Louis as Global Gateway for Healthcare Innovation
Mercy Helps Position St. Louis as Global Gateway for Healthcare Innovation


About BioSTL Global 

BioSTL Global is the international arm of BioSTL, tasked with elevating St. Louis’ reputation around the world as a leading agricultural and healthcare ecosystem. BioSTL Global actively recruits high-potential bio-innovation startups to enter the U.S. market through St. Louis, and connects them with major regional healthcare systems, corporations, investors, and research institutions to help them succeed, and the local ecosystem grow.

About BioSTL 

For 25 years, BioSTL has served as the backbone of St. Louis’ bioscience innovation ecosystem, bringing together research institutions, startups, industry partners, investors, and global collaborators to accelerate impact. BioSTL advances innovation across agriculture and human health through global engagement initiatives, including the BioSTL Global Health Innovation Summit; through BioGenerator, its startup creation and investment arm; and through education-to-workforce programs that build a strong, inclusive talent pipeline. Together, these efforts position St. Louis as a globally connected center for bioscience-driven growth. Find out more at www.BioSTL.org.

About Health Innovation Networks 

There are 15 health innovation networks, commissioned by NHS England and the Office for Life Sciences, to operate as the key innovation arm of the NHS. They are the health innovation adoption experts. They find, test, implement and scale innovation to improve health outcomes, increase productivity and support economic growth. They act as a bridge between health care providers, commissioners, academia and industry. By connecting these sectors, they help to build a pipeline of solutions for the NHS from research and product development to implementation and commercialization. Find out more at www.healthinnovationyh.org.uk/.

LEAVE A REPLY

Please enter your comment!
Please enter your name here